Alexander H. Stegh, PhD, a leading brain cancer scientist, has been named research director of the Brain Tumor Center at Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.
Established last year, the Brain Tumor Center brings together the collective expertise of Washington University neurosurgeons, adult and pediatric oncologists, radiation oncologists, otolaryngologists, neurologists, neuroradiologists, pathologists and endocrinologists to provide leading-edge, multidisciplinary care for brain tumor patients. Such physicians and physician-scientists also work together with the center’s scientists to understand how and why brain tumors develop and to conduct transformative research aimed at advancing patient care and clinical outcomes.
“Dr. Alexander Stegh is a national leader in the study of glioblastoma, one of the most aggressive forms of brain cancer,” said Gregory J. Zipfel, MD, head of the Department of Neurosurgery and the Ralph G. Dacey Distinguished Professor of Neurosurgery at the School of Medicine. “With his extensive expertise discovering genetic drivers of glioblastoma and his success in translating nanoparticle-based precision medicine approaches to brain cancer patients, the Brain Tumor Center at Siteman is gaining a visionary scientific leader who will help the center achieve its overall goal of discovering new therapies that will lead to improved outcomes for brain tumor patients.”